| Validity of the clinical dementia rating scale for the detection and staging of dementia in Brazilian patients MLF Chaves, AL Camozzato, C Godinho, R Kochhann, A Schuh, ... Alzheimer Disease & Associated Disorders 21 (3), 210-217, 2007 | 264 | 2007 |
| Iron and oxidative stress in Parkinson’s disease: an observational study of injury biomarkers MS Medeiros, A Schumacher-Schuh, AM Cardoso, GV Bochi, ... PloS one 11 (1), e0146129, 2016 | 165 | 2016 |
| Application of the Brazilian version of the CDR scale in samples of dementia patients ALG Maia, C Godinho, ED Ferreira, V Almeida, A Schuh, J Kaye, ... Arq. Neuro-Psiquiatr. 64 (2B), 485-489, 2006 | 120 | 2006 |
| Interleukin-6 serum levels in patients with Parkinson’s disease KW Hofmann, AFS Schuh, J Saute, R Townsend, D Fricke, R Leke, ... Neurochemical research 34, 1401-1404, 2009 | 106 | 2009 |
| DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson’s disease patients M Rieck, AF Schumacher-Schuh, V Altmann, CLM Francisconi, ... Pharmacogenomics 13 (15), 1701-1710, 2012 | 102 | 2012 |
| The Parkinson's disease genome‐wide association study locus browser FP Grenn, JJ Kim, MB Makarious, H Iwaki, A Illarionova, K Brolin, ... Movement Disorders 35 (11), 2056-2067, 2020 | 98 | 2020 |
| Aplicação da versão brasileira da escala de avaliação clínica da demência (Clinical Dementia Rating-CDR) em amostras de pacientes com demência ALG Maia, C Godinho, ED Ferreira, V Almeida, A Schuh, J Kaye, ... Arquivos de neuro-psiquiatria 64, 485-489, 2006 | 98 | 2006 |
| A randomized, phase 2 clinical trial of lithium carbonate in Machado‐Joseph disease JAM Saute, RM de Castilhos, TL Monte, AF Schumacher‐Schuh, ... Movement Disorders 29 (4), 568-573, 2014 | 81 | 2014 |
| Neuropsychiatric symptoms in patients with dementia associated with increased psychological distress in caregivers during the COVID-19 pandemic WV Borelli, MC Augustin, PBF De Oliveira, LC Reggiani, ... Journal of Alzheimer's Disease 80 (4), 1705-1712, 2021 | 77 | 2021 |
| Characterizing the genetic architecture of Parkinson's disease in Latinos DP Loesch, ARVR Horimoto, K Heilbron, EI Sarihan, M Inca‐Martinez, ... Annals of neurology 90 (3), 353-365, 2021 | 74 | 2021 |
| The impact of dysphagia therapy on quality of life in patients with Parkinson's disease as measured by the swallowing quality of life questionnaire (SWALQOL) A Ayres, GP Jotz, CRM Rieder, AFS Schuh, MR Olchik International archives of otorhinolaryngology 20, 202-206, 2016 | 71 | 2016 |
| Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study M Rizig, S Bandres-Ciga, MB Makarious, OO Ojo, PW Crea, OV Abiodun, ... The Lancet Neurology 22 (11), 1015-1025, 2023 | 65 | 2023 |
| Underrepresented populations in Parkinson's genetics research: current landscape and future directions AF Schumacher‐Schuh, A Bieger, O Okunoye, KY Mok, SY Lim, ... Movement Disorders 37 (8), 1593-1604, 2022 | 59 | 2022 |
| Peripheral oxidative stress biomarkers in spinocerebellar ataxia type 3/Machado–Joseph disease AM de Assis, JAM Saute, A Longoni, CB Haas, VR Torrez, AW Brochier, ... Frontiers in neurology 8, 485, 2017 | 58 | 2017 |
| Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment V Altmann, AF Schumacher-Schuh, M Rieck, SM Callegari-Jacques, ... Neuroscience letters 615, 88-91, 2016 | 55 | 2016 |
| Is there a Role for ADORA2A Polymorphisms in Levodopa-Induced Dyskinesia in Parkinson’s Disease Patients? M Rieck, AF Schumacher-Schuh, SM Callegari-Jacques, V Altmann, ... Pharmacogenomics 16 (6), 573-582, 2015 | 51 | 2015 |
| Plastic changes induced by neonatal handling in the hypothalamus of female rats EC Winkelmann-Duarte, AS Todeschin, MC Fernandes, LC Bittencourt, ... Brain research 1170, 20-30, 2007 | 51 | 2007 |
| Advances in proteomic and metabolomic profiling of neurodegenerative diseases A Schumacher-Schuh, A Bieger, WV Borelli, MK Portley, PS Awad, ... Frontiers in Neurology 12, 792227, 2022 | 47 | 2022 |
| Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson's disease V Altmann, AF Schumacher-Schuh, M Rieck, SM Callegari-Jacques, ... Pharmacogenomics 17 (5), 481-488, 2016 | 46 | 2016 |
| Parkinson’s disease pharmacogenomics: new findings and perspectives AF Schumacher-Schuh, CRM Rieder, MH Hutz Pharmacogenomics 15 (9), 1253-1271, 2014 | 43 | 2014 |
Mara H. HutzDEPARTAMENTO DE GENETICA, UNIVERSIDADE FEDERAL DO RIO GRANDE DO SULVerified email at ufrgs.br
